Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development.

Research output: Contribution to journalArticlepeer-review

348 Downloads (Pure)

Abstract

Sphingolipids are abundant in the microvillar membrane of intestinal epithelial cells where they are essential for structural integrity and may act as receptors for toxins, virus and bacteria. Metabolism of dietary and membrane sphingolipids in the intestine generates ceramide, sphingosine, sphingosine-1-phosphate, and ceramide-1-phosphate, via the action of alkaline sphingomyelinase, neutral ceramidase, sphingosine-1-kinase, and ceramide-1-kinase. These intermediary metabolites act as bioactive lipid messengers, influencing numerous cellular functions including growth, differentiation and apoptosis of both epithelial and immunocompetent cells in the gastrointestinal tract, and also the progress of inflammation and responsiveness of the mucosal cells to pathogens. This review summarizes background and recent progress in the metabolism of dietary and endogenous sphingolipids in the gut and its pathophysiological implications.
Original languageEnglish
Pages (from-to)62-72
JournalProgress in lipid research
Volume48
Issue number1
DOIs
Publication statusPublished - 2009

Subject classification (UKÄ)

  • Other Clinical Medicine

Fingerprint

Dive into the research topics of 'Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development.'. Together they form a unique fingerprint.

Cite this